It’s been a mixed bag this week for Eastman Kodak, the storied camera giant that won a now-imperiled $765 million federal coronavirus drug manufacturing deal last month. An independent review commissioned by the company found that executives who cashed out by exercising stock options the day before the deal was announced likely acted legally. But the top watchdog for the agency behind the huge government loan also announced that it’s investigating the deal.


Accountable.US, a watchdog group, nonetheless pointed to Trump’s prior business arrangements with Kodak as a red flag that something improper may have occurred. “Kodak paid millions of dollars to sponsor Trump’s reality show career,” said Kyle Herrig, the group’s president, in an emailed statement.

“Claims that the president had nothing to do with his administration’s effort to spend nearly a billion tax dollars transforming the company into a pharmaceutical giant is laughable. A thorough, independent investigation is clearly warranted.”

back to top